Shares of Geron Corporation (GERN) tumbled 5.30% in pre-market trading on Wednesday, following the release of its first quarter 2025 financial results. Despite beating analyst estimates on some key metrics, investors appeared to focus on the company's continued net loss and high operating expenses.
Geron reported a Q1 EPS of -$0.03, surpassing the IBES estimate of -$0.04. The company's operating income came in at -$16.704 million, also better than the estimated -$23.5 million. However, these improvements were overshadowed by a substantial net loss of $19.835 million for the quarter.
A major concern for investors seems to be Geron's high operating expenses, which reached $56.307 million in Q1. This significant spending, likely related to ongoing research and development efforts, appears to be weighing heavily on the company's financial performance and investor sentiment. The pre-market plunge suggests that market participants may be growing impatient with the company's path to profitability, despite its progress in narrowing losses compared to analyst expectations.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。